← Evidence map

ArticleFrontiers in cellular neuroscience2024

Donepezil as a new therapeutic potential in KCNQ2- and KCNQ3-related autism.

Andreea Nissenkorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39175503